Pharma Focus Asia
KP - Sustainable Packaging Solutions

Klöckner Pentaplast Builds Klöckner Barrier Film (KBF) Facility

Introduction:

Klöckner Pentaplast plans to expand its Klöckner Barrier Film (KBF) facility, located in central Virginia in the United States. Through this expansion, the company intendsto support the growing pharmaceuticals market.

Features:

The expansion project designed with amulti-million dollar investmentwill enhance the facility’s capacity by 6,000 metric tonnes. Moreover, the new facility will add innovative coating capabilities, which in turn will enhance the company’s ability to greatly serve the growing demand for pharmaceuticals market in the North American region with high-quality pharmaceutical films.

The increased coating capabilities will enhance the packaging needs of pharmaceutical manufacturers. As the market continues to expand, the need for high-barrier solutions will grow and hence sensitive pharmaceuticals must be protected from moisture and oxygen.

This additional facility expansion will help customers achieve new performance levels in barrier protection.

The expanded facility is scheduled to be to be operational towards the end of 2021.

Specifications:

NameKlöckner Pentaplast
TypeExpansion
Year2021
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024CPHI Chine || PMEC China 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024CPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?